Seven percent of persons with HIV infection report cost saving-related nonadherence to prescription medication, according to research published in the Dec. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...
Dec 13, 2019
0
1
Pre-exposure prophylaxis (PrEP) – taking antiretroviral drugs to protect people from acquiring HIV infection—is revolutionising the prevention of HIV around the world. However, a global study led by Monash University ...
Dec 12, 2019
0
2
Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection, suggests a study of human cells and tissues by researchers at the National Institutes of Health and the University ...
Dec 11, 2019
0
15
Researchers have cleared a major obstacle in the development of an HIV vaccine, proving in animal models that effective, yet short-lasting antibodies can be coaxed into multiplying as a fighting force against the virus.
Dec 5, 2019
1
409
From 2013 to 2017, the number of new HIV infections remained stable, and only 18.1 percent of the 1.2 million people with indications for pre-exposure prophylaxis (PrEP) had been prescribed the medication in 2018, according ...
Dec 5, 2019
0
1
AIDS has no cure. HIV is still here. But some people are forgetting that.
Nov 29, 2019
0
5
When babies are born with HIV, starting treatment within hours to days is better than waiting even the few weeks to months that's the norm in many countries, researchers reported Wednesday.
Nov 27, 2019
0
42
1.7 million. That's how many people are infected with the human immunodeficiency virus (HIV) each year worldwide. 1.7 million people who are condemned to lifelong antiretroviral therapy (ART) or risk developing fatal AIDS ...
Nov 26, 2019
2
55
Wound healing events in mucous tissues during early infection by Simian Immunodeficiency Virus, or SIV, guard some primate species against developing AIDS, a recent study has learned. The research looked at why certain species ...
Nov 22, 2019
0
63
An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety of ...
Nov 20, 2019
3
1687
